At present, a confirmed positive-related correlation of PD-L1expression and the efficacy of anti-PD-1/PD-L1 inhibitors have been observed in non-small cell lung cancer (NSCLC) and melanoma; yet, whether a similar relationship would exist in digestive tumors is still unclear. Here, CD274 is linked to non-small cell lung carcinoma.